RMD vs. ^SP500TR

In the year-to-date period, RMD achieves a 11.27% return, which is significantly higher than ^SP500TR's 1.92% return. Over the past 10 years, RMD has outperformed ^SP500TR with an annualized return of 17.52%, while ^SP500TR has yielded a comparatively lower 12.86% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and S&P 500 Total Return (^SP500TR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current RMD Sharpe Ratio is 0.51, which is comparable to the ^SP500TR Sharpe Ratio of 0.72. The chart below compares the historical Sharpe Ratios of RMD and ^SP500TR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

The maximum RMD drawdown since its inception was -61.60%, which is greater than ^SP500TR's maximum drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for RMD and ^SP500TR. For additional features, visit the drawdowns tool.

ResMed Inc. (RMD) has a higher volatility of 9.85% compared to S&P 500 Total Return (^SP500TR) at 5.42%. This indicates that RMD's price experiences larger fluctuations and is considered to be riskier than ^SP500TR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.